Your browser is no longer supported. Please, upgrade your browser.
Settings
KERX Keryx Biopharmaceuticals Inc. daily Stock Chart
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.30 Insider Own0.80% Shs Outstand104.63M Perf Week4.65%
Market Cap776.35M Forward P/E- EPS next Y-0.31 Insider Trans-1.66% Shs Float101.71M Perf Month23.46%
Income-136.40M PEG- EPS next Q-0.28 Inst Own64.50% Short Float17.12% Perf Quarter44.08%
Sales19.30M P/S40.23 EPS this Y3.30% Inst Trans-0.36% Short Ratio12.57 Perf Half Y115.70%
Book/sh0.47 P/B15.79 EPS next Y69.80% ROA-66.50% Target Price9.00 Perf Year-19.87%
Cash/sh- P/C- EPS next 5Y- ROE-134.80% 52W Range2.80 - 9.59 Perf YTD46.93%
Dividend- P/FCF- EPS past 5Y-27.90% ROI-62.00% 52W High-22.63% Beta4.01
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin59.10% 52W Low165.00% ATR0.30
Employees184 Current Ratio3.10 Sales Q/Q466.70% Oper. Margin- RSI (14)67.41 Volatility4.25% 4.75%
OptionableYes Debt/Eq2.19 EPS Q/Q-40.60% Profit Margin- Rel Volume0.59 Prev Close7.51
ShortableYes LT Debt/Eq2.19 EarningsAug 03 BMO Payout- Avg Volume1.39M Price7.42
Recom2.20 SMA208.24% SMA5018.31% SMA20049.09% Volume821,645 Change-1.20%
Jul-08-16Reiterated Maxim Group Buy $7 → $9
Mar-30-16Reiterated FBR Capital Outperform $10 → $13
Feb-29-16Upgrade FBR Capital Mkt Perform → Outperform $10
Feb-26-16Upgrade Raymond James Mkt Perform → Outperform
Feb-26-16Reiterated Stifel Buy $10 → $9
Feb-26-16Downgrade JP Morgan Overweight → Neutral
Feb-25-16Reiterated Maxim Group Buy $11 → $5
Oct-05-15Upgrade Morgan Stanley Underweight → Equal-Weight
Sep-09-15Initiated Raymond James Mkt Perform
Sep-03-15Initiated Citigroup Sell
Aug-13-15Initiated Morgan Stanley Underweight $3
Aug-11-15Initiated FBR Capital Mkt Perform $10
Aug-10-15Downgrade ROTH Capital Buy → Neutral $11 → $6
Aug-06-15Reiterated Maxim Group Buy $17 → $11
Jul-23-15Reiterated ROTH Capital Buy $23 → $11
May-06-15Reiterated Mizuho Buy $25 → $21
May-05-15Reiterated ROTH Capital Buy $27 → $23
May-05-15Reiterated Maxim Group Buy $32 → $17
Apr-20-15Reiterated Stifel Buy $19 → $17
Mar-20-15Reiterated Oppenheimer Outperform $22 → $18
Jul-19-16 09:53AM  Will Keryx Biopharmaceuticals (KERX) Continue to Surge Higher?
Jul-15-16 09:14AM  Coverage Initiated on Select Biotech Stocks
Jul-14-16 11:12AM  Kamich's 10 Stocks Under $10
Jul-11-16 06:19AM  [$$] Keryx Stock Seen Reaching $9 at Barrons.com
Jul-06-16 02:32PM  ETFs with exposure to Keryx Biopharmaceuticals, Inc. : July 6, 2016
Jun-30-16 12:36PM  5 Hot Stocks to Watch Right Now
Jun-27-16 07:12PM  Cramer: If the data's good, this stock could get a takeout bid at CNBC
08:00AM  Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy GlobeNewswire
Jun-24-16 07:22AM  Keryx Biopharmaceuticals Has Gained 19.8% So Far in 2016 -- Here's Why at Motley Fool -5.48%
Jun-23-16 08:00AM  Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors GlobeNewswire
Jun-21-16 05:20PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
08:00AM  Keryx Biopharmaceuticals Appoints Two New Board Members GlobeNewswire
Jun-15-16 09:02AM  Premarket Research Report Covering the Biotech Industry
Jun-14-16 08:30AM  Keryx Biopharmaceuticals to Present at JMPs Life Science Conference on Tuesday, June 21 GlobeNewswire
Jun-02-16 04:08PM  6 Biotechs Seriously on the Move at 24/7 Wall St. +11.87%
01:49PM  Why Keryx Biopharmaceuticals Shouldn't Be Up Today at Motley Fool
12:06PM  Here's a Reason Why Keryx (KERX) Stock Is Spiking Today
May-27-16 04:35PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
May-23-16 05:16PM  ETFs with exposure to Keryx Biopharmaceuticals, Inc. : May 23, 2016
May-05-16 05:31PM  ETFs with exposure to Keryx Biopharmaceuticals, Inc. : May 5, 2016
03:47PM  Here's Why Keryx Biopharmaceuticals Jumped 18.2% in April at Motley Fool
01:04PM  KERYX BIOPHARMACEUTICALS INC Financials
May-04-16 11:50AM  Keryx Biopharmaceuticals, Inc. :KERX-US: Earnings Analysis: Q1, 2016 By the Numbers -7.62%
Apr-29-16 01:30PM  Keryx (KERX) Q1 Loss in Line, Auryxia Up on Strong Demand (Revised)
Apr-28-16 04:59PM  Edited Transcript of KERX earnings conference call or presentation 28-Apr-16 12:00pm GMT
09:31AM  Keryx Biopharma reports 1Q loss
09:04AM  3 Healthcare Stocks Billionaires Love Right Now at Motley Fool
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:46AM  Keryx (KERX) Reports Wider-Than-Expected Loss in Q1 Zacks
07:32AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:07AM  Q1 2016 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open CCBN
07:00AM  Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results GlobeNewswire
Apr-27-16 12:10PM  Drug Stocks' Earnings Previews: KERX, BXLT, BMRN, AGEN, IMGN Zacks
Apr-25-16 09:50AM  What's in Store for Keryx (KERX) this Earnings Season? Zacks
Apr-14-16 08:30AM  Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2016 Financial Results on Thursday, April 28, 2016 GlobeNewswire
Apr-01-16 08:31AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
08:30AM  Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors GlobeNewswire
06:07AM  Biotech Stock Mailbag: Intercept, Acadia, Keryx, Galena at TheStreet
Mar-30-16 03:20PM  Keryx Up on Positive Auryxia Data in Iron Deficiency Anemia
10:20AM  Is Propanc Health Group the Next Breakthrough Biotech Company Accesswire
Mar-29-16 02:39PM  Why Keryx Biopharmaceuticals Ironed Out a Higher Stock Price at Motley Fool +8.57%
01:56PM  Why is Keryx Biopharma Stock (KERX) Soaring Today?
01:55PM  Why These 5 Stocks Are Big Gainers Today at Insider Monkey
11:50AM  Keryx shares jump on successful trial results from iron deficiency drug at bizjournals.com
10:31AM  Keryx Biopharmaceuticals (KERX) Stock Shoots Up on Positive Anemia Drug Results at TheStreet
10:28AM  Stocks to Buy: Four Stocks to Consider on (3/29/16) Accesswire
08:56AM  Keryx stock up 21% after positive late-stage results for anemia drug at MarketWatch
08:00AM  Keryx Biopharmaceuticals Inc Phase 3 IDA/CKD Results Call scheduled for 8:00 am ET today
07:17AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:30AM  Keryx says anemia drug succeeds in study of kidney patients Reuters
06:30AM  Keryx Biopharmaceuticals Announces Positive Top-line Results from Pivotal Phase 3 Study of Ferric Citrate for the Treatment of Iron Deficiency Anemia in Adults with Non-Dialysis Dependent Chronic Kidney Disease GlobeNewswire
Mar-28-16 08:01AM  Biotech Sector Report Analyst; Expecting FDA Results Accesswire
Mar-21-16 08:15AM  Keryx Biopharmaceuticals (KERX) Jumps: Stock Rises 10.1%
Mar-11-16 04:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events
Mar-02-16 01:48PM  Keryx Biopharmaceuticals, Inc. Value Analysis (NASDAQ:KERX) : March 2, 2016 +10.93%
Mar-01-16 08:30AM  Keryx Biopharmaceuticals to Present at Cowen and Companys 36th Annual Health Care Conference on Monday, March 7 GlobeNewswire +6.97%
08:12AM  Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : KERX-US : March 1, 2016
Feb-29-16 11:07AM  Keryx Biopharmaceuticals, Inc. Earnings Analysis: 2015 By the Numbers +10.44%
06:18AM  Keryx Biopharma upgraded by FBR Capital
Feb-26-16 05:26PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 10-K, Annual Report +8.98%
01:07PM  [$$] Keryx May Have the Cash to Get to Breakeven at Barrons.com
09:50AM  Keryx Posts Wider-than-Expected Loss in Q4, Auryxia Grows
09:28AM  Why Did JPMorgan Just Downgrade Keryx Bio?
Feb-25-16 04:14PM  Edited Transcript of KERX earnings conference call or presentation 25-Feb-16 1:00pm GMT
02:17PM  Keryx's (KERX) Q4 Loss Wider-Than-Expected (revised)
09:56AM  Keryx Biopharma reports 4Q loss
09:21AM  Keryx's (KERX) Q4 Loss Wider-Than-Expected
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:32AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q4 2015 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open
07:00AM  Keryx Biopharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results GlobeNewswire
Feb-22-16 03:40PM  Can Keryx (KERX) Surprise Investors this Earnings Season?
Feb-15-16 10:28AM  Billionaire Seth Klarmans Top Biotech Stock Picks at Insider Monkey
Feb-11-16 08:00AM  Keryx Biopharmaceuticals to Host Conference Call on Fourth Quarter and Year End 2015 Financial Results on Thursday, February 25, 2016 GlobeNewswire
Feb-10-16 08:00AM  Early Briefing on Biotechnology Stocks -- Achillion Pharma, CTI BioPharma, Inovio Pharma, and Keryx Biopharma Accesswire
Feb-09-16 05:46PM  Why Keryx Biopharmaceuticals Inc. Plunged 26% in January at Motley Fool
Jan-26-16 03:04PM  Klarman Gives Insight on Keryx Biopharmaceuticals Investment +10.12%
Jan-14-16 09:04AM  Why Keryx Biopharmaceuticals Dropped 64% in 2015 at Motley Fool
Jan-12-16 08:02AM  These Biotech Stocks Could Double in 2016 at Motley Fool
Jan-04-16 01:27PM  Keryx Biopharmaceuticals, Inc. Value Analysis (NASDAQ:KERX) : January 4, 2016
Dec-31-15 08:06AM  Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 31, 2015
Dec-22-15 04:05PM  Keryx Biopharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11 GlobeNewswire -6.88%
Dec-21-15 02:07PM  XBI Recovers from Its Slump +7.99%
Dec-17-15 08:00AM  Technical Briefing on Biotechnology Equities -- Keryx Biopharma, Cytokinetics, Curis, and BioTime Accesswire
Dec-11-15 08:30AM  Equities Lead Investor Sentiment - Research Reports on TriNet Group, Xencor, Keryx Biopharmaceuticals and TeleCommunication Systems Accesswire -9.09%
Dec-10-15 04:39PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and +5.11%
08:00AM  Keryx Announces Appointment of John P. Butler to its Board of Directors GlobeNewswire
Dec-08-15 08:50AM  Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 8, 2015
Dec-05-15 10:50AM  Hedge Funds Are Selling Keryx Biopharmaceuticals (KERX) at Insider Monkey
Dec-01-15 09:05AM  Keryx Biopharmaceuticals Announces Webcast of Presentation at Oppenheimer's 26th Annual Healthcare Conference GlobeNewswire
Nov-21-15 01:56PM  A10 Networks Inc (ATEN) Growing In Popularity Among Top Investors at Insider Monkey
Nov-08-15 12:38PM  Why Keryx Biopharmaceuticals Rallied 40% in October at Motley Fool
Nov-03-15 04:05PM  Keryx Biopharmaceuticals Announces Participation at Two Upcoming Investor Conferences GlobeNewswire +10.88%
Oct-30-15 11:24AM  XBI Fell the Most as the Small-Caps Took a Hit
10:20AM  Keryx Q3 Loss Wider-than-Expected, Auryxia in Focus
Oct-29-15 10:06PM  Edited Transcript of KERX earnings conference call or presentation 29-Oct-15 12:00pm GMT +12.75%
01:57PM  Did Keryx Biopharmaceuticals Inc Finally Turn The Corner? at Motley Fool
08:51AM  Keryx Biopharma reports 3Q loss
08:25AM  Keryx's (KERX) Q3 Loss Wider-Than-Expected
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, as well as treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis. The company has licensing and collaboration agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Auryxia in Japan. It also has strategic alliance with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adams BrianVP and General CounselJul 15Sale7.011,0837,592103,320Jul 18 07:10 PM
Madison GregPresident and CEOJul 05Sale6.669366,234258,745Jul 06 04:17 PM
Adams BrianVP and General CounselJul 05Sale6.666604,396104,403Jul 06 04:18 PM
Madison GregPresident and CEOMay 09Sale5.421,87310,152259,681May 10 04:35 PM
Neylan John F.Chief Medical OfficerApr 25Sale5.214,76624,83193,984Apr 27 04:16 PM
Adams BrianVP and General CounselApr 15Sale5.051,0605,353105,063Apr 18 08:25 PM
Madison GregPresident and CEOApr 05Sale4.501,0784,851261,554Apr 07 05:01 PM
Adams BrianVP and General CounselApr 05Sale4.507593,416106,123Apr 07 05:00 PM
Madison GregPresident and CEOFeb 09Sale3.231,9386,260262,632Feb 10 05:23 PM
Adams BrianVP and General CounselJan 15Sale3.301,3224,36353,132Jan 20 05:05 PM
Adams BrianVP and General CounselJan 06Sale5.163,00415,50154,454Jan 06 09:44 PM
Madison GregPresident and CEOJan 06Sale4.834,26120,581110,820Jan 06 09:43 PM
Madison GregPresident and CEONov 09Sale5.181,6388,485115,081Nov 12 05:00 PM
Holmes Scott AChief Financial OfficerNov 04Buy5.401,3287,17159,742Nov 05 05:01 PM
Holmes Scott AChief Financial OfficerNov 03Buy5.303,67219,45858,414Nov 05 05:01 PM
Adams BrianVP and General CounselOct 15Sale4.011,0114,05457,458Oct 19 05:33 PM
Holmes Scott AChief Financial OfficerAug 21Buy5.725,00028,59054,742Aug 24 06:06 PM
Madison GregPresident and CEOAug 20Buy5.699,98456,759116,719Aug 24 06:10 PM
Neylan John F.Chief Medical OfficerAug 12Buy6.2010,00062,00055,000Aug 14 07:30 AM
Madison GregPresident and CEOAug 10Sale6.071,68310,216106,735Aug 12 07:00 PM
Holmes Scott AChief Financial OfficerJul 31Sale7.872,75821,70549,742Aug 03 07:30 PM